|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.51 AUD | -1.47% |
|
-13.04% | -26.71% |
| 02-10 | Australian shares little changed as financials cap mining gains | RE |
| 02-04 | Xero's US Business Shifiting Primarily Toward Payments, Jefferies Says | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 828M | 1.05B | 1.33B | 1.63B | 1.98B | |||||
Other Revenues, Total | 20.68M | 47.2M | 73.61M | 83.01M | 124M | |||||
Total Revenues | 849M | 1.1B | 1.4B | 1.71B | 2.1B | |||||
Cost of Goods Sold, Total | 119M | 139M | 178M | 203M | 230M | |||||
Gross Profit | 730M | 957M | 1.22B | 1.51B | 1.87B | |||||
Selling General & Admin Expenses, Total | 414M | 547M | 640M | 726M | 892M | |||||
R&D Expenses | 250M | 372M | 490M | 526M | 618M | |||||
Other Operating Expenses | 4.38M | 7.79M | - | - | - | |||||
Other Operating Expenses, Total | 668M | 927M | 1.13B | 1.25B | 1.51B | |||||
Operating Income | 61.69M | 30.3M | 91.98M | 259M | 363M | |||||
Interest Expense, Total | -33.62M | -36.1M | -42.8M | -44.51M | -79.13M | |||||
Interest And Investment Income | 5.16M | 4.08M | 29.12M | 67.48M | 136M | |||||
Net Interest Expenses | -28.46M | -32.02M | -13.68M | 22.97M | 57.36M | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | -9.99M | -2.47M | -4.54M | 8.4M | -51.86M | |||||
EBT, Excl. Unusual Items | 23.23M | -4.2M | 73.77M | 290M | 368M | |||||
Restructuring Charges | - | - | -34.69M | -3.01M | - | |||||
Merger & Related Restructuring Charges | - | -2.5M | - | - | - | |||||
Impairment of Goodwill | - | -20.38M | -94.9M | - | - | |||||
Asset Writedown | - | -4.31M | -27.78M | -24.48M | -3.04M | |||||
Other Unusual Items | -67.17M | 33.76M | 7.93M | -685K | -2.44M | |||||
EBT, Incl. Unusual Items | -43.94M | 2.36M | -75.68M | 262M | 363M | |||||
Income Tax Expense | -63.71M | 11.48M | 37.86M | 87.27M | 135M | |||||
Earnings From Continuing Operations | 19.77M | -9.11M | -114M | 175M | 228M | |||||
Net Income to Company | 19.77M | -9.11M | -114M | 175M | 228M | |||||
Net Income - (IS) | 19.77M | -9.11M | -114M | 175M | 228M | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | 19.77M | -9.11M | -114M | 175M | 228M | |||||
Net Income to Common Excl. Extra Items | 19.77M | -9.11M | -114M | 175M | 228M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.14 | -0.06 | -0.76 | 1.15 | 1.49 | |||||
Basic EPS - Continuing Operations | 0.14 | -0.06 | -0.76 | 1.15 | 1.49 | |||||
Basic Weighted Average Shares Outstanding | 144M | 148M | 150M | 151M | 153M | |||||
Net EPS - Diluted | -2.66 | -0.06 | -0.76 | 1.14 | 1.47 | |||||
Diluted EPS - Continuing Operations | -2.66 | -0.06 | -0.76 | 1.14 | 1.47 | |||||
Diluted Weighted Average Shares Outstanding | 150M | 150M | 150M | 153M | 155M | |||||
Normalized Basic EPS | 0.1 | -0.02 | 0.31 | 1.2 | 1.51 | |||||
Normalized Diluted EPS | 0.1 | -0.02 | 0.31 | 1.19 | 1.49 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 73.61M | 44.22M | 106M | 272M | 376M | |||||
EBITA | 63.79M | 33.23M | 95.04M | 262M | 365M | |||||
EBIT | 61.69M | 30.3M | 91.98M | 259M | 363M | |||||
EBITDAR | 79.68M | 53.5M | 115M | 281M | 386M | |||||
Total Revenues (As Reported) | 849M | 1.1B | 1.4B | 1.71B | 2.1B | |||||
Effective Tax Rate - (Ratio) | 145.01 | 485.7 | -50.02 | 33.32 | 37.18 | |||||
Total Current Taxes | 9.41M | 10.09M | 35.46M | 26.06M | 72.2M | |||||
Total Deferred Taxes | -16.33M | 20.74M | 2.4M | 61.21M | 62.65M | |||||
Normalized Net Income | 14.52M | -2.63M | 46.1M | 181M | 230M | |||||
Interest on Long-Term Debt | 33.62M | 41.22M | 42.8M | 44.51M | 58.75M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 92.59M | 145M | 167M | 240M | 305M | |||||
Selling and Marketing Expenses | 308M | 406M | 472M | 541M | 664M | |||||
General and Administrative Expenses | 106M | 142M | 168M | 185M | 228M | |||||
Research And Development Expense From Footnotes | 266M | 389M | 530M | 578M | 649M | |||||
Net Rental Expense, Total | 6.07M | 9.28M | 9.4M | 9.04M | 9.96M | |||||
Imputed Operating Lease Interest Expense | 2.26M | 2.72M | 2.97M | 2.72M | 4.92M | |||||
Imputed Operating Lease Depreciation | 3.82M | 6.56M | 6.42M | 6.32M | 5.04M | |||||
Stock-Based Comp., Other (Total) | 42.73M | 61.06M | 80.86M | 95.82M | 152M | |||||
Total Stock-Based Compensation | 42.73M | 61.06M | 80.86M | 95.82M | 152M |
- Stock Market
- Equities
- XRO Stock
- Financials Xero Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















